Rhabdomyolysis: a rare adverse effect of levetiracetam

A 62-year-old previously healthy male was admitted with new onset generalised tonic-clonic seizures. Treatment was initiated with the antiepileptic levetiracetam and he had no further episodes of seizures. Creatine kinase (CPK) level was 1812 IU/L 12-hour postadmission. Despite good hydration, his C...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :BMJ Case Rep
Главные авторы: Thomas, Liza, Mirza, Madiha Muhammed Farooq, Shaikh, Niaz Ahmed, Ahmed, Nahla
Формат: Artigo
Язык:Inglês
Опубликовано: BMJ Publishing Group 2019
Предметы:
Unexpected Outcome (Positive or Negative) Including Adverse Drug Reactions
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6720964/
https://ncbi.nlm.nih.gov/pubmed/31451475
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2019-230851
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы